Php213 - A Retrospective Review of Reimbursement Decisions by the Haute Autorité De Santé in 2017 - Underlying Rationale for Medicinal Products With Insufficient Actual Medical Benefit
Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1107
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV